The study was stopped early because of high mortality rate among patients with hypoxemic respiratory failure in the intervention arm ( 8/8 , 100 % ) compared with the control arm ( 7/10 , 70 % ; relative risk , 1.43 ; 95 % CI , 0.95-2 .14 ) .